UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
PL206255B1
(pl)
|
2000-07-21 |
2010-07-30 |
Dendreon Corporationdendreon Corporation |
Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii
|
EP1628674A2
(en)
|
2003-05-06 |
2006-03-01 |
Cytovia, Inc. |
Protease inhibitors for coronaviruses and sars-cov and the use thereof
|
WO2004101781A1
(en)
|
2003-05-13 |
2004-11-25 |
Universität Zu Lübeck |
Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors
|
US20060014821A1
(en)
|
2003-08-27 |
2006-01-19 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of SARS 3C like protease
|
US7462594B2
(en)
|
2003-12-31 |
2008-12-09 |
Taigen Biotechnology Co., Ltd. |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
|
WO2005113580A1
(en)
|
2004-05-21 |
2005-12-01 |
Pfizer Inc. |
Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
WO2006061714A2
(en)
|
2004-12-09 |
2006-06-15 |
Pfizer Inc. |
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
JP2009508963A
(ja)
|
2005-09-21 |
2009-03-05 |
インサイト・コーポレイション |
アミド化合物および医薬組成物としてのその使用
|
EP1783228A1
(en)
|
2005-11-08 |
2007-05-09 |
ETH Zürich |
Recombinant expression of multiprotein complexes using polygenes
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
KR20150033726A
(ko)
|
2006-07-05 |
2015-04-01 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
|
US7737174B2
(en)
|
2006-08-30 |
2010-06-15 |
The Regents Of The University Of Michigan |
Indole inhibitors of MDM2 and the uses thereof
|
US8222288B2
(en)
|
2006-08-30 |
2012-07-17 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of MDM2 and the uses thereof
|
CA2679426A1
(en)
|
2007-02-27 |
2008-09-04 |
Luc Farmer |
Inhibitors of serine proteases
|
WO2008144507A2
(en)
|
2007-05-16 |
2008-11-27 |
President And Fellows Of Harvard College |
Spirooxindole inhibitors of aurora kinase
|
KR101396696B1
(ko)
|
2007-10-10 |
2014-05-16 |
노파르티스 아게 |
스피로피롤리딘, 및 hcv 및 hiv 감염에 대한 그의 용도
|
EP2240483B8
(en)
|
2008-01-09 |
2013-04-03 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
JP5490778B2
(ja)
|
2008-03-20 |
2014-05-14 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
C型肝炎ウイルス阻害剤としてのフッ素化大環状化合物
|
KR101811235B1
(ko)
|
2009-06-05 |
2017-12-21 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
T 세포 및 조혈 세포의 재프로그래밍
|
WO2011047174A1
(en)
|
2009-10-14 |
2011-04-21 |
Xenon Pharmaceuticals Inc. |
Synthetic methods for spiro-oxindole compounds
|
NZ600430A
(en)
|
2009-11-12 |
2014-06-27 |
Univ Michigan |
Spiro-oxindole mdm2 antagonists
|
US9008723B2
(en)
|
2010-01-08 |
2015-04-14 |
United States Foundation For Inspiration And Recognition Of Science And Technology |
Wireless adapter
|
KR101861168B1
(ko)
|
2010-06-15 |
2018-05-31 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
작은 부피의 말초 혈액으로부터의 유도된 만능 줄기 세포의 생성
|
NZ611866A
(en)
|
2010-11-12 |
2015-04-24 |
Univ Michigan |
Spiro-oxindole mdm2 antagonists
|
MY160077A
(en)
|
2011-01-21 |
2017-02-15 |
Univ Sains Malaysia |
Curcumin compounds and their preparations thereof
|
US9474759B2
(en)
|
2011-09-27 |
2016-10-25 |
Kansas State University Research Foundation |
Broad-spectrum antivirals against 3C or 3C-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
|
AU2012368189B2
(en)
|
2011-12-29 |
2017-08-31 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetase-Fc conjugates
|
US9828342B2
(en)
|
2012-02-24 |
2017-11-28 |
City Of Hope |
Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof
|
US9309284B2
(en)
|
2012-05-02 |
2016-04-12 |
Kansas State University Reasearch Foundation |
Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
|
WO2014040129A1
(en)
|
2012-09-12 |
2014-03-20 |
The University Of Queensland |
Protease-based biosensor
|
JP6359560B2
(ja)
|
2012-12-31 |
2018-07-18 |
サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. |
複素環式化合物及びその使用方法
|
RU2018138576A
(ru)
|
2013-01-11 |
2019-04-02 |
Импоссибл Фудз Инк. |
Немолочный аналог сыра, содержащий коацерват
|
US20160068820A9
(en)
|
2013-02-08 |
2016-03-10 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Novel Nylanderia Pubens Virus
|
CA2907046C
(en)
|
2013-03-15 |
2021-04-20 |
Atyr Pharma, Inc. |
Histidyl-trna synthetase-fc conjugates
|
US10196444B2
(en)
|
2013-07-29 |
2019-02-05 |
Bluebird Bio, Inc. |
Multipartite signaling proteins and uses thereof
|
US9772328B2
(en)
|
2013-09-12 |
2017-09-26 |
The University Of Queensland |
Bimolecular protease-based biosensor
|
GB201320351D0
(en)
|
2013-11-18 |
2014-01-01 |
Erasmus Universiteit Medisch Ct |
Method
|
WO2015164308A1
(en)
|
2014-04-22 |
2015-10-29 |
Merck Sharp & Dohme Corp. |
FACTOR XIa INHIBITORS
|
MX2016013964A
(es)
|
2014-04-25 |
2017-04-06 |
Bluebird Bio Inc |
Receptores de antigenos quimericos del promotor mnd.
|
US10023879B2
(en)
|
2014-06-04 |
2018-07-17 |
Fate Therapeutics, Inc. |
Minimal volume reprogramming of mononuclear cells
|
DK3151672T3
(da)
|
2014-06-06 |
2021-02-01 |
Bluebird Bio Inc |
Forbedrede t-celle-sammensætninger
|
WO2016014522A1
(en)
|
2014-07-21 |
2016-01-28 |
Brandeis University |
Inhibitors of deubiquitinating proteases
|
GB201413020D0
(en)
|
2014-07-23 |
2014-09-03 |
Pribright The Inst |
Coronavirus
|
US9328147B2
(en)
|
2014-09-05 |
2016-05-03 |
Chung Yuan Christian University |
Recombinant baculovirus vector and uses thereof
|
ES2895640T3
(es)
|
2014-12-12 |
2022-02-22 |
2Seventy Bio Inc |
Receptores de antígenos quiméricos de BCMA
|
CN113769079A
(zh)
|
2015-02-27 |
2021-12-10 |
衣阿华州立大学研究基金会股份有限公司 |
猪流行性腹泻病毒株和由其产生的免疫原性组合物
|
US10784994B2
(en)
|
2015-08-21 |
2020-09-22 |
Lg Electronics Inc. |
Method for transmitting information for LTE-WLAN aggregation system and a device therefor
|
WO2017044507A2
(en)
|
2015-09-08 |
2017-03-16 |
Sirnaomics, Inc. |
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
|
SG10201913587WA
(en)
|
2016-02-05 |
2020-02-27 |
Denali Therapeutics Inc |
Inhibitors of receptor-interacting protein kinase 1
|
US10590084B2
(en)
|
2016-03-09 |
2020-03-17 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
US9975885B2
(en)
|
2016-04-28 |
2018-05-22 |
Purdue Research Foundation |
Broad-spectrum non-covalent coronavirus protease inhibitors
|
US11021513B2
(en)
|
2016-05-13 |
2021-06-01 |
Emory University |
Peptidomimetics for the treatment of norovirus infection
|
SG11201810352XA
(en)
|
2016-06-08 |
2018-12-28 |
Acraf |
New antibacterial compounds
|
US11013779B2
(en)
|
2016-06-20 |
2021-05-25 |
Kansas State University Research Foundation |
Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses
|
US11033600B2
(en)
|
2016-07-28 |
2021-06-15 |
Kansas State University Research Foundation |
Protease transition state inhibitor prodrugs
|
TW201817714A
(zh)
|
2016-08-30 |
2018-05-16 |
英商葛蘭素史密斯克藍智慧財產權有限公司 |
抑制3c及3cl蛋白酶之化合物及其使用方法
|
PE20191153A1
(es)
|
2016-09-28 |
2019-09-05 |
Blade Therapeutics Inc |
Moduladores de calpainas y usos terapeuticos de los mismos
|
MX2019014100A
(es)
|
2017-05-25 |
2020-02-07 |
Bluebird Bio Inc |
Variantes de endonucleasas cblb, composiciones y metodos de uso.
|
KR20200083552A
(ko)
|
2017-11-02 |
2020-07-08 |
아이쿠리스 게엠베하 운트 코. 카게 |
B형 간염 바이러스 (hbv)에 활성인 신규 고활성 피라졸로-피페리딘 치환된 인돌-2-카르복스아미드
|
JP2021501764A
(ja)
|
2017-11-02 |
2021-01-21 |
アイクリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
B型肝炎ウイルス(hbv)に対して有効な新規高活性アミノチアゾール置換インドール−2−カルボキサミド
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
EP3867253A4
(en)
|
2018-10-16 |
2022-05-18 |
Ikena Oncology, Inc. |
INDOL AHR INHIBITOR AND USES THEREOF
|
SG11202111236UA
(en)
|
2019-04-30 |
2021-11-29 |
Aicuris Gmbh & Co Kg |
Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
|
WO2020247665A1
(en)
|
2019-06-05 |
2020-12-10 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
US11045546B1
(en)
|
2020-03-30 |
2021-06-29 |
Cytodyn Inc. |
Methods of treating coronavirus infection
|
US20230105838A1
(en)
|
2020-04-05 |
2023-04-06 |
Pfizer Inc. |
Method of Treating COVID-19
|
WO2021207409A2
(en)
|
2020-04-08 |
2021-10-14 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
|
WO2021206877A1
(en)
|
2020-04-10 |
2021-10-14 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
AU2021254045A1
(en)
|
2020-04-10 |
2022-10-13 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
US11124497B1
(en)
|
2020-04-17 |
2021-09-21 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
EP4146267A1
(en)
|
2020-05-08 |
2023-03-15 |
The Board of Trustees of the Leland Stanford Junior University |
Protease inhibitors for treatment or prevention of coronavirus disease
|
IL298529A
(en)
|
2020-06-09 |
2023-01-01 |
Pardes Biosciences Inc |
Cysteine protease inhibitors and methods of using them
|
US11174231B1
(en)
|
2020-06-09 |
2021-11-16 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
IL298324A
(en)
|
2020-06-10 |
2023-01-01 |
Aligos Therapeutics Inc |
Antiviral compounds for the treatment of coronavirus, picornavirus and novovirus infections
|
EP4178955A1
(en)
|
2020-07-11 |
2023-05-17 |
Pfizer Inc. |
Antiviral heteroaryl ketone derivatives
|
BR112022026899A2
(pt)
|
2020-07-20 |
2023-01-24 |
Enanta Pharm Inc |
Composto representado pela fórmula (i) ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método de tratamento ou prevenção de uma infecção por vírus, método de inibição da protease 3c viral ou protease 3cl viral em um mamífero e método de tratamento de um distúrbio respiratório
|
US10959969B1
(en)
|
2020-07-24 |
2021-03-30 |
Lanny L Johnson |
Methods of treating SARS Cov-2 virus with protocatechuic acid
|
WO2022020711A1
(en)
|
2020-07-24 |
2022-01-27 |
The Texas A&M University System |
Sars-cov-2 main protease inhibitors
|
CN115960088B
(zh)
|
2020-07-31 |
2024-07-26 |
四川大学 |
一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途
|
MX2023001756A
(es)
|
2020-08-13 |
2023-05-04 |
Enanta Pharm Inc |
Peptidos funcionalizados como agentes antivirales.
|
US11351149B2
(en)
|
2020-09-03 |
2022-06-07 |
Pfizer Inc. |
Nitrile-containing antiviral compounds
|
US11384090B2
(en)
|
2020-11-23 |
2022-07-12 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
US20230103494A1
(en)
|
2020-11-23 |
2023-04-06 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
US11352363B1
(en)
|
2020-11-23 |
2022-06-07 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
WO2022109363A1
(en)
|
2020-11-23 |
2022-05-27 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
US11976084B2
(en)
|
2020-11-23 |
2024-05-07 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
MX2023012178A
(es)
|
2021-04-16 |
2024-01-05 |
Fujian Akeylink Biotechnology Co Ltd |
Compuesto de peptído corto de prolina modificado con anillo y uso del mismo.
|
US11970502B2
(en)
|
2021-05-04 |
2024-04-30 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic antiviral agents
|
US20220402926A1
(en)
|
2021-05-11 |
2022-12-22 |
Enanta Pharmaceuticals, Inc. |
Novel macrocyclic spiropyrrolidine derived antiviral agents
|
US11319325B1
(en)
|
2021-05-11 |
2022-05-03 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic spiropyrrolidine derived antiviral agents
|
US20240285598A1
(en)
|
2021-05-28 |
2024-08-29 |
Arun K. Ghosh |
Compounds for the treatment of sars
|
KR20240057384A
(ko)
|
2021-06-02 |
2024-05-02 |
아세아 테라퓨틱스 인코포레이티드 |
항바이러스제로서의 프로테아제 억제제
|
WO2023286844A1
(ja)
|
2021-07-15 |
2023-01-19 |
国立研究開発法人国立国際医療研究センター |
抗ウイルス活性等の生理活性を有する化合物
|
US20230115107A1
(en)
|
2021-07-23 |
2023-04-13 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
US11339170B1
(en)
|
2021-07-23 |
2022-05-24 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
US11325916B1
(en)
|
2021-07-29 |
2022-05-10 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
US20230122228A1
(en)
|
2021-07-29 |
2023-04-20 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
WO2023086350A1
(en)
|
2021-11-12 |
2023-05-19 |
Enanta Pharmaceuticals, Inc. |
Alkyne-containing antiviral agents
|
US11919910B2
(en)
|
2021-11-12 |
2024-03-05 |
Enanta Pharmaceuticals, Inc. |
Spiropyrrolidine derived antiviral agents
|
WO2023086352A1
(en)
|
2021-11-12 |
2023-05-19 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
US20230159546A1
(en)
|
2021-11-18 |
2023-05-25 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
US11993600B2
(en)
|
2021-12-08 |
2024-05-28 |
Enanta Pharmaceuticals, Inc. |
Saturated spirocyclics as antiviral agents
|
CN114057624B
(zh)
|
2021-12-10 |
2023-09-12 |
贵州大学 |
一种茶香酮拼接氧化吲哚类化合物及其制备方法及应用
|
CN115894504A
(zh)
|
2022-10-21 |
2023-04-04 |
深圳信立泰药业股份有限公司 |
一种冠状病毒3cl蛋白酶抑制剂及其用途
|